Actinogen Medical Share Price and Company Fundamentals
Last traded: Today at 5:10 AM
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer's disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Key Metrics
PE ratio
-
PB ratio
8.00
Dividend yield
-
Beta
1.05
Market cap
$153.20M
Enterprise value
$139.26M
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://actinogen.com.au |
| Mailing address | 109 Pitt Street Suite 901, Level 9 Sydney NSW 2000 Australia |
| Phone / Fax | 61 2 8964 7401 / 61 2 8964 7588 |
Dividends
More: Actinogen Medical Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Actinogen Medical paid $- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.ACW dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Actinogen Medical.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D. | MD, CEO & Director | 66 | |
| Mr. William Edward Souter BCom, IPAA, LLB (Adel) | Chief Financial Officer | ||
| Dr. Dana C. Hilt M.D. | Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board | 72 | |
| Mr. Andrew B. Udell B.Sc., M.B.A. | Chief Commercial Officer | 55 | |
| Mr. Michael Roberts | Head of Investor Relations & Corporate Communications | ||
| Prof. Paul Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D. | Head of Clinical Pharmacology & Lead Physician and Depression | ||
| Dr. Fujun Li Ph.D. | Head of Manufacturing | ||
| Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D. | Company Secretary | 62 |
Profitability and management effectiveness
Profit margin
-268.37%
Operating margin
-127.38%
Return on assets
-41.91%
Return on equity
-77.47%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Actinogen Medical is 153.20M and its enterprise value is 139.26M. The enterprise value to revenue ratio of ACW is 25.37. The enterprise value to EBITDA ratio of ACW is -9.28.
The ACW's stocks Beta value is 1.05 making it 5% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Actinogen Medical (ACW)
Actinogen Medical (ASX:ACW) Frequently Asked Questions
1. What is Actinogen Medical's Stock Symbol?
Actinogen Medical trades on ASX under the ticker symbol "ACW".
2. What is Actinogen Medical's stock price today?
One share of ACW stock can currently be purchased for approximately $0.048.
3. How can I contact Actinogen Medical?
Actinogen Medical's mailing address is 109 Pitt Street Suite 901, Level 9 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 8964 7401.
4. What is Actinogen Medical's official website?
The official website of Actinogen Medical is https://actinogen.com.au.